Search for: "N. LILLY"
Results 161 - 180
of 267
Sort by Relevance
|
Sort by Date
7 Jun 2011, 8:51 am
Supp.2d 1095, 1129 n.108 (D. [read post]
2 Jun 2011, 12:46 pm
Rptr.2d 377, 385 n.14 (Cal. [read post]
26 May 2011, 10:54 am
Supp.2d 741, 743 n.2 (S.D. [read post]
11 May 2011, 4:54 am
ARUP: Genetic testing patents found to be anticipated and in violation of Lilly written description requirement (Holman’s Biotech IP Blog) (Patent Docs) (Patently-O) US: FDA gets the ball rolling on biosimilar/interchangeable biological product user fee program; proposal gives a hat tip to PDUFA while acknowledging the nascent state of the industry (FDA Law Blog) (Patent Docs) Products Citalopram – UK Patents Court disapproving of EPO’s approach to assessment of novelty:… [read post]
2 May 2011, 3:14 pm
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
30 Apr 2011, 5:22 am
” Eli Lilly & Co. v. [read post]
30 Apr 2011, 5:00 am
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
29 Apr 2011, 1:03 pm
" Eli Lilly & Co. v. [read post]
28 Apr 2011, 3:18 pm
Id. at 308 & n.9. [read post]
18 Apr 2011, 4:00 am
Compare In re Application of Eli Lilly & Co. [read post]
15 Apr 2011, 6:02 am
Eli Lilly & Co., 2011 WL 1259650 (W.D. [read post]
16 Mar 2011, 3:25 pm
What’s Happening in Washington Dan Jaffe, Executive Vice President, Government Relations, ANA It’s within our power to affect how present challenges are resolved. [read post]
8 Mar 2011, 1:23 pm
Eli Lilly and Co., 598 F.3d 1336 (Fed. [read post]
24 Feb 2011, 1:49 pm
Janssen Pharmaceutica, Inc., 2006 WL 3665417, at *4 n.2 (S.D. [read post]
19 Feb 2011, 3:32 pm
M-I LLC, 514 F.3d 1244, 1256 n.7 (Fed. [read post]
3 Feb 2011, 2:11 pm
A few weeks ago a regular reader, and occasional correspondent, Prof. [read post]
11 Jan 2011, 1:06 pm
Mellon Bank, (East) PSFS, Nat’l Ass’n. v. [read post]
27 Oct 2010, 8:30 am
Written by Michael Davitz M.D. [read post]
19 Oct 2010, 12:20 pm
Id. at *4 n.3. [read post]
6 Oct 2010, 4:22 am
(profitability through simplicity) US: Yeda Appeals Board decision favoring Abbott in TBP-II interference (Holman’s Biotech IP Blog) US: Jury finds Scruggs wilfully infringed Monsanto patents, awards at least $9 million in damages (Holman’s Biotech IP Blog) US: Marcy Kaptur’s bill to create a compulsory license for patented seeds: the Seed Availability and Competition Act of 2009 (KEI) US: Glaxosmithkline Biologicals seeks review of BPAI decision concerning isolated protein from B… [read post]
